Boston Scientific stock jumps on $126M profit report

Boston Scientific stock jumps on $126M profit report

WORCESTER BUSINESS JOURNAL – Marlborough medical device giant Boston Scientific’s stocks rose 6% Wednesday morning after the company reported a $126-million profit on $2.7 billion in sales for the third quarter, exceeding the company’s guidance range for sales.

Earnings per share for the quarter were 9 cents due to acquisition-related charges in the quarter primarily associated with the acquisition of British cancer treatment device maker BTG plc, according to the company. The adjusted earnings per share were 39 cents compared to the guidance range of 37 to 39 cents per share.

Read the full article by Sam Bonacci here.